Back to Newsroom
Back to Newsroom

Puration Cannabis Infused Beverage Operation Prioritized In Canadian Deal

Tuesday, 20 March 2018 09:25 AM

Puration Inc.

Topic:

DALLAS, TX / ACCESSWIRE / March 20, 2018 / Puration, Inc. (OTC PINK: PURA) today announced its patented cannabis extraction capacity and corresponding cannabis-infused beverage business has been pushed to the top priority in the previously announced deal in Canada that Puration is working on with North American Cannabis Holdings, Inc. (OTC PINK: USMJ). Together, USMJ and PURA have been developing an opportunity to acquire a grow operation in Canada in advance of the pending nationwide legalization of recreational marijuana expected this coming July. The comprehensive acquisition deal includes PURA establishing and extraction facility and cannabis-infused beverage operation. PURA now expects to close the extraction and beverage operation business in advance of the grow operation acquisition. The extraction and beverage business deal is anticipated to be finalized as early as by the end of this week. The comprehensive acquisition deal remains on track and a letter of intent on the USMJ acquisition of the grow operation remains imminent.

For more information on Puration, visit http://www.aciconglomerated.com.

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350

SOURCE: Puration, Inc.

Topic:
Back to newsroom
Back to Newsroom
Share by: